TECH

52.69

0.50% 0.26

Handel nachbörslich: 52.69

Bio Techne Corp (TECH)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$52.43

Offen:

$52.69

24-Stunden-Volumen:

1.60M

Relative Volume:

0.70

Marktkapitalisierung:

$8.24B

Einnahmen:

$1.22B

Nettoeinkommen (Verlust:

$81.07M

KGV:

102.49

EPS:

0.5141

Netto-Cashflow:

$223.02M

1W Leistung:

+3.70%

1M Leistung:

-8.95%

6M Leistung:

+4.38%

1J Leistung:

-12.15%

1-Tages-Spanne:

$52.02

$53.23

1-Wochen-Bereich:

$50.02

$53.53

52-Wochen-Spanne:

$46.01

$72.16

Bio Techne Corp Stock (TECH) Company Profile

Firmenname

Bio Techne Corp

Sektor

Healthcare (1114)

Branche

Biotechnology (623)

Telefon

612-379-8854

Adresse

614 MCKINLEY PL N E, MINNEAPOLIS, MN

Mitarbeiter

3,100

Twitter

@biotechne

Nächster Verdiensttermin

2024-10-30

Neueste SEC-Einreichungen

TECH's Discussions on Twitter

Compare TECH vs VRTX, REGN, ALNY, ARGX, INSM

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
TECH Bio Techne Corp	52.69	8.20B	1.22B	81.07M	223.02M	0.5141
VRTX Vertex Pharmaceuticals Inc	454.97	113.96B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	749.47	78.41B	14.34B	4.50B	3.77B	41.56
ALNY Alnylam Pharmaceuticals Inc	328.70	40.85B	3.71B	313.75M	465.38M	2.2571
ARGX Argen X Se Adr	697.05	42.05B	4.16B	1.29B	734.26M	19.58
INSM Insmed Inc	148.31	29.99B	606.42M	-1.28B	-997.58M	-6.403

Bio Techne Corp Stock (TECH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-09-03	Hochstufung	RBC Capital Mkts	Sector Perform → Outperform
2025-08-21	Hochstufung	Citigroup	Neutral → Buy
2025-07-22	Fortgesetzt	Stephens	Overweight
2025-07-09	Eingeleitet	TD Cowen	Buy
2025-05-30	Eingeleitet	Wells Fargo	Overweight
2025-04-09	Herabstufung	KeyBanc Capital Markets	Overweight → Sector Weight
2025-03-18	Eingeleitet	Evercore ISI	Outperform
2025-02-19	Herabstufung	Robert W. Baird	Outperform → Neutral
2024-05-22	Herabstufung	Citigroup	Buy → Neutral
2024-02-08	Eingeleitet	Scotiabank	Sector Outperform
2024-02-02	Herabstufung	Stifel	Buy → Hold
2023-12-07	Eingeleitet	UBS	Buy
2023-08-28	Eingeleitet	William Blair	Outperform
2023-01-10	Hochstufung	Wells Fargo	Underweight → Equal Weight
2022-12-14	Eingeleitet	Deutsche Bank	Buy
2022-12-12	Hochstufung	Citigroup	Neutral → Buy
2022-12-07	Eingeleitet	RBC Capital Mkts	Sector Perform
2022-08-25	Eingeleitet	Credit Suisse	Outperform
2022-04-25	Herabstufung	Wells Fargo	Equal Weight → Underweight
2021-09-15	Hochstufung	KeyBanc Capital Markets	Sector Weight → Overweight
2021-03-08	Hochstufung	Stephens	Equal-Weight → Overweight
2021-02-23	Hochstufung	Stifel	Hold → Buy
2021-01-25	Bestätigt	The Benchmark Company	Buy
2020-11-10	Eingeleitet	KeyBanc Capital Markets	Sector Weight
2020-09-30	Eingeleitet	Atlantic Equities	Overweight
2020-07-15	Herabstufung	Stephens	Overweight → Equal-Weight
2020-05-27	Herabstufung	Stifel	Buy → Hold
2020-05-14	Eingeleitet	The Benchmark Company	Buy
2020-01-08	Fortgesetzt	Stephens	Overweight
2020-01-08	Eingeleitet	Wells Fargo	Equal Weight
2020-01-07	Eingeleitet	Citigroup	Neutral
2019-11-15	Eingeleitet	Stifel	Buy
2019-07-02	Hochstufung	Janney	Neutral → Buy
2019-01-14	Hochstufung	Stephens	Equal-Weight → Overweight
2018-10-31	Herabstufung	Craig Hallum	Buy → Hold
2018-10-17	Eingeleitet	Goldman	Neutral
2018-06-15	Eingeleitet	Argus	Buy
2017-07-13	Eingeleitet	Wells Fargo	Market Perform
2017-02-09	Eingeleitet	Citigroup	Buy
2017-01-18	Eingeleitet	Deutsche Bank	Buy
2016-11-10	Fortgesetzt	Leerink Partners	Outperform
2015-01-21	Bestätigt	Robert W. Baird	Outperform
2013-09-20	Hochstufung	Robert W. Baird	Neutral → Outperform

Alle ansehen

Bio Techne Corp Aktie (TECH) Neueste Nachrichten

06:51 AM

Bio-Techne Advances Spatial Biology with Modular Expansion of COMET™ Suite - The AI Journal

06:51 AM

06:44 AM

Tudor Investment Corp ET AL Purchases Shares of 242,016 Bio-Techne Corp $TECH - MarketBeat

Mar 22, 2026

JPMorgan Chase Sells Stake in Bio-Techne Corp - National Today

Mar 22, 2026

JPMorgan Chase & Co. Sells 633,738 Shares of Bio-Techne Corp $TECH - MarketBeat

Mar 22, 2026

Mar 21, 2026

38,300 Shares in Bio-Techne Corp $TECH Purchased by Covea Finance - MarketBeat

Mar 21, 2026

After a Long Reset Period, Life Science Stocks Look Set to Rebound - Morningstar

Mar 21, 2026

Mar 20, 2026

How Is Bio-Techne's Stock Performance Compared to Other Biotechnology Stocks - inkl

Mar 20, 2026

ELISpot & FluoroSpot Assay Market Report 2026-2031: Mabtech, Oxford Immunotec Global, and Cellular Technology Dominate the Landscape - GlobeNewswire Inc.

Mar 20, 2026

TECH SEC FilingsBio-Techne Corp 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 20, 2026

Bio-Techne Corp (NASDAQ:TECH) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Mar 20, 2026

Mar 19, 2026

Bio-Techne Corp. stock outperforms competitors on strong trading day - MarketWatch

Mar 19, 2026

Mar 18, 2026

Bio-Techne Corp. stock underperforms Monday when compared to competitors - MSN

Mar 18, 2026

Mar 17, 2026

Should You Continue to Hold Bio-Techne Stock in Your Portfolio? - Yahoo Finance

Mar 17, 2026

Risk Check: Will Bio Techne Corporation outperform the market in YEAR2026 Levels & Fast Moving Market Watchlists - baoquankhu1.vn

Mar 17, 2026

Bio-Techne stock falls on AI software concerns, TD Cowen sees buy opportunity - Investing.com

Mar 17, 2026

Mairs & Power Inc. Has $156.18 Million Stock Position in Bio-Techne Corp $TECH - MarketBeat

Mar 17, 2026

Mar 16, 2026

April McClain Delaney makes multiple stock transactions in Bio-Techne, BJ’s Wholesale, and C.H Robinson - Investing.com Nigeria

Mar 16, 2026

Trading the Move, Not the Narrative: (TECH) Edition - Stock Traders Daily

Mar 16, 2026

Hollow Brook Wealth Management Increases Stake in Bio-Techne Corp - National Today

Mar 16, 2026